Faculty Profile

Martin G. Sanda, MD

Martin G. Sanda, MD

Professor of Urology and Chair, Department of Urology, Emory University School of Medicine

Email: martinsanda@emory.edu


American Board of Urology


Dr. Sanda is an internationally recognized prostate cancer surgeon and scientist. In 2013, he was was appointed chair of the Department of Urology at Emory University School of Medicine and urology service chief for Emory Healthcare. He will also serve as director of the Prostate Cancer Center, which will be established within Emory's Winship Cancer Institute.

Dr. Sanda came to Emory from Harvard Medical School and Beth Israel Deaconess Medical Center, where he served as director of the Prostate Cancer Center. He was also the co-leader of the Prostate Cancer Program at the Dana Farber Cancer Center.

After receiving his MD degree at Columbia University, Dr. Sanda did his general surgery residency at the Medical College of Virginia, and completed his surgical oncology fellowship at the National Cancer Institute. His urology residency was undertaken at Johns Hopkins Hospital.

His clinical practice, which includes robotic prostatectomy and robotic cystectomy, is focused on developing new surgical and non-surgical approaches to cancer care and to improving the quality of life among cancer survivors.

Dr. Sanda is principal investigator of three multi-center consortium studies funded by the National Cancer Institute and the Prostate Cancer Foundation: the first is seeking to develop urine tests for detecting prostate cancer, the second is developing benchmarks for improving quality of life among cancer survivors, and the third is working to develop innovative prostate cancer vaccines. These studies have enrolled over 4,400 patients, and their findings thus far have been published in leading medical journals including Journal of the American Medical Association and The New England Journal of Medicine.

Dr. Sanda has served as chair of the Prostate and Genito-Urinary Collaborative Group of the National Cancer Institute's Early Detection Research Network; has spearheaded two nationwide, NCI Cooperative Group prostate cancer clinical trials; has served on numerous federal funding review panels; and has been a member of the Research Council of the American Urological Association since 2011. He has more than 160 peer-reviewed publications, and his work has been cited more than 5,000 times in biomedical literature.


View Dr. Sanda's publications in PubMed.


  • Emory University Hospital

  • Emory Saint Joseph's Hospital
  • The Emory Clinic


  • BA, Molecular Biophysics and Biochemistry, Yale University, Cum Laude, New Haven, CT, 1979-1983

  • MD, Columbia University, New York, NY, Class of 1987

  • Surgery Residency, Medical College of Virginia, Richmond, VA, 1987-1989

  • Urology Residency, Johns Hopkins Hospital, Baltimore, MD, 1991-1995

  • Surgical Oncology & Immunology Fellowship, National Institute of Health, Bethesda, MD, 1989-1991

Honors and Awards

  • J. Hartwell Harrison Memorial Resident Education Award, Harvard-Longwood Urology Residency, 2012

  • Visiting Professor, Memorial Sloan Kettering Cancer Center, 2012

  • Honorary Degree, Master of Arts, Harvard University, 2011

  • Service Recognition Award for Three-Year Term as Chair, EDRN Prostate/GU Collaborative Group, National Cancer Institute, 2010

  • Leadership Development for Physicians at Academic Health Centers (Select Course at Harvard School of Public Health), Nominated by Senior Leadership at BIDMC, 2010

  • Best of Boston, Top Doctors, Urology, Boston Magazine, 2005-2012

  • Young Investigator Award, Society of Urological Oncology, 2005

Clinical Interests

  • Abnormal PSA

  • Benign prostatic hyperplasia (BPH)

  • Bladder cancer/tumors

  • Hematuria

  • Prostate cancer

Research Interests

  • Prostate cancer

  • Prostate cancer vaccines

  • Quality of life improvement for cancer survivors

  • Novel approaches to cancer care

««return to top